Berrin Önalan

Berrin Önalan

Auto-generated profile, based on publicly available information

Berrin Önalan

Clinic of General Surgery, Kanuni Sultan Süleyman Training and Research Hospital, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2022 in Turkish Journal of Surgery
Verified
Journal Article
Open access
PDF file
NGNihat Gülaydın
Nihat Gülaydın
RIRaim İlIaz
Raim İlIaz
AÖAtakan Özkan
Atakan Özkan
AGA Hande Gökçe
A Hande Gökçe
HÖHanifi Önalan
Hanifi Önalan
AAAziz Arı
Aziz Arı
Objective: latrogenic colon perforation (ICP) is one of the most feared complications of colonoscopy and causes unwanted morbidity and mortality. In this study, we aimed to discuss the characteristics of the cases of ICP we encountered in our endoscopy clinic, its etiology, our treatment approaches, and results in the light of the current literature. Material and Methods: We retrospectively evaluated the cases of ICP among 9.709 lower gastrointestinal system endoscopy procedures (colonoscopy + rectosigmoidoscopy) performed for diagnostic purposes in our endoscopy clinic during 2002-2020. Results: A total of seven cases of ICP were detected. The diagnosis was made during the procedure in six patients and after eight hours in one patient, and their treatment was performed urgently. Whereas surgical procedures were performed in all patients, the type of the procedure varied; laparoscopic primary repair was performed in two patients and laparotomy in five patients. In the patients who underwent laparotomy, primary repair was performed in three patients, partial colon resection and end-to-end anastomosis in one patient, and loop colostomy in one patient. The patients were hospitalized for an average of 7.14 days. The patients who did not develop complications in the postoperative follow-up were discharged with full recovery. Conclusion: Prompt diagnosis and appropriate treatment of ICP is crucial to prevent morbidity and mortality.

5 January 2022 in Acta Chirurgica Belgica
Verified
Journal Article
Closed access
TATansu Altintaş
Tansu Altintaş
NÖN. Berrin Dodur Önalan
N. Berrin Dodur Önalan
MKMehmet Celal Kızılkaya
Mehmet Celal Kızılkaya
NGNermin Gündüz
Nermin Gündüz
MBMehmet Abdussamet Bozkurt
Mehmet Abdussamet Bozkurt
There is no clear consensus as to which topical hemostatic agent is best used during cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. The aim of this study was to evaluate the effect of hyperthermic chemotherapy on the biomechanical properties of organic topical hemostatic agents and histologically fibrin formation rates. Four topical hemostatic agents (Spongostan™, Surgicel®, Fibrillar™, Arista®) were evaluated. All agents were mixed with 3 ml blood in sterile tubes separately to form clot formation. The resulting clot formations were incubated with 36 °C and 42 °C with saline or cisplatin for 1 h. Strength and flexibility of hemostatic samples were evaluated under weight of 0 g, 50 g, 100 g, 200 g and 300 g. All samples were stained with hemotoxylin-eosin and compared histologically for fibrin clot formation under light microscope. There were no statistically significant differences according to strength and flexibility of topical hemostatic agents on hyperthermic chemotherapy. Histopathologically, the highest fibrin formation was observed in Surgicel®, followed by Fibrillar™. The least fibrin formation was detected in Arista®. This study demonstrated that exposure to hyperthermic chemotherapy did not significantly affect the biomechanical properties of organic topical hemostatic agents and the fibrin clot formation.

8 January 2022
Verified
Book
Open access
PDF file
ZBZekiye Karaca Bozdağ
Zekiye Karaca Bozdağ
BÇBuse Naz Çandır
Buse Naz Çandır
TŞTuğçe Bölme Şavlı
Tuğçe Bölme Şavlı
SSSüleyman Sönmez
Süleyman Sönmez
AOAziz Ocakoğlu
Aziz Ocakoğlu
İSİsmail Hakkı Alp Solak
İsmail Hakkı Alp Solak
Memenin Embriyolojisi ve Anatomisi Zekiye KARACA BOZDAĞ Buse Naz ÇANDIR Meme Hastalıklarında Patoloji Tuğçe BÖLME ŞAVLI Meme Radyolojisi Süleyman SÖNMEZ Mastodini Aziz OCAKOĞLU Hakan BÖLÜKBAŞI Selim Meme Hastalıkları Fadime Didem TRABULUS Hüsnü ŞEVİK Meme Kanserinde Korunma ve Tarama Stratejileri Yahya Kemal ÇALIŞKAN Meme Kanserinin Klinik Özellikleri, Tanı ve Evreleme Oğuzhan TEKİN Meme Kanserinde Sistemik Tedavi Yaklaşımları Sevinç DAĞIŞTANLI Meme Kanseri Tedavisinde Radyoterapi Yusuf BİLGİN Meme Kanserinin Cerrahi Tedavisi Berrin ÖNALAN Onkoplastik Meme Cerrahisi Tansu ALTINTAŞ Meme Kanserinde İzlem İsmail Hakkı Alp SOLAK

1 January 2026 in Comprehensive Medicine
Verified
Journal Article
Open access
DÖDodur Önalan
Dodur Önalan
NBNezihe Berrin
Nezihe Berrin
MAMahmut Ozan Aydın
Mahmut Ozan Aydın
MOMahmut Ozan
Mahmut Ozan
CÖCenk Özkan
Cenk Özkan
HAHalil Alış
Halil Alış